NCT00660829

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies

Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 in Subjects With Seasonal Allergic Rhinitis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 536 (actual)
• Sponsor: Meda Pharmaceuticals · Industry
• Sex: All
• Age: 12 Years
• Healthy volunteers: Not accepted

Summary

The Purpose of this study is to determine if one allergy medication (0.15% azelastine hydrochloride) is more effective than Placebo alone.

Conditions

• Seasonal Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	Placebo	Placebo
DRUG	0.15% Azelastine Hydrochloride	0.15% Azelastine Hydrochloride 822 mcg

Timeline

• Start date: 2007-12-01
• Primary completion: 2008-02-01
• Completion: 2008-04-01
• First posted: 2008-04-17
• Last updated: 2015-04-13
• Results posted: 2010-01-28

Locations

6 sites across 1 country: United States